
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

TRAIN Newsletter — July 2024

An Update from MI Health—July 2024

FasterCures Quarterly Update—July 2024

Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
